Genexine Market Cap

Genexine has a market cap or net worth of 194.88 billion as of January 16, 2026. Its market cap has decreased by -26.37% in one year.

Market Cap

194.88B

Enterprise Value

n/a

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,285.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 194.88B, an increase of 78.76%. That is a compound annual growth rate of 3.62%.

Market Cap History

Date	Market Cap	% Change
Jan 16, 2026	198.75B	-6.72%
Dec 30, 2025	213.07B	-12.27%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1.46T	-52.47%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	88.92T
Celltrion	45.73T
ALTEOGEN	26.53T
ABL Bio	10.89T
SK Biopharmaceuticals	9.26T
Yuhan	7.91T
HLB Co., Ltd.	6.97T
Sam Chun Dang Pharm.	6.49T

Market Cap Rankings